Funding agencies: Dr. Hogarth has received grant support from the NBIA Disorders Association.
Letters: New Observations
Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation
Article first published online: 13 MAR 2013
© 2013 International Parkinson and Movement Disorder Society
Volume 28, Issue 10, pages 1462–1463, September 2013
How to Cite
Goldman, J. G., Eichenseer, S. R., Berry-Kravis, E., Zimnowodzki, S., Gregory, A., Hogarth, P. and Hayflick, S. J. (2013), Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation. Mov. Disord., 28: 1462–1463. doi: 10.1002/mds.25410
Relevant conflicts of interest/financial disclosures: Drs. Goldman, Eichenseer, Berry-Kravis, Zimnowodzki, and Haylick and Ms. Gregory do not have any related financial disclosures or conflicts of interest.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 23 SEP 2013
- Article first published online: 13 MAR 2013
- Manuscript Accepted: 15 JAN 2013
- Manuscript Revised: 10 JAN 2013
- Manuscript Received: 19 AUG 2012
This article has been cited by:
- 1Pathophysiology and Treatment of Neurodegeneration With Brain Iron Accumulation in the Pediatric Population, Current Treatment Options in Neurology, 2013, 15, 5, 652, , ,